211 related articles for article (PubMed ID: 37627129)
1. Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists.
Zheng W
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627129
[TBL] [Abstract][Full Text] [Related]
2. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
3. Emerging Advances in Endometrial Cancer: Integration of Molecular Classification into Staging for Enhanced Prognostic Accuracy and Implications for Racial Disparities.
Ogunmuyiwa J; Williams V
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539507
[TBL] [Abstract][Full Text] [Related]
4. 2023 FIGO staging system for endometrial cancer: The evolution of the revolution.
Gaffney D; Matias-Guiu X; Mutch D; Scambia G; Creutzberg C; Fotopoulou C; Berek JS; Concin N
Gynecol Oncol; 2024 Mar; 184():245-253. PubMed ID: 38447389
[TBL] [Abstract][Full Text] [Related]
5. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
[TBL] [Abstract][Full Text] [Related]
6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
7. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
Cokmez H; Yilmaz A
Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
[TBL] [Abstract][Full Text] [Related]
8. [Application and clinical significance of TCGA molecular classification in endometrial cancer].
Zhao LY; Dai YB; Li LW; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):697-704. PubMed ID: 34823319
[No Abstract] [Full Text] [Related]
9. Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A; Høgdall C; Schnack T
Gynecol Oncol; 2022 Jun; 165(3):506-513. PubMed ID: 35346512
[TBL] [Abstract][Full Text] [Related]
10. The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.
Rathod PS; Shakuntala PN; Pallavi VR; Kundaragi R; Shankaranand B; Vijay CR; Devi KU; Bafna UD
Indian J Surg Oncol; 2014 Jun; 5(2):109-14. PubMed ID: 25114462
[TBL] [Abstract][Full Text] [Related]
11. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification.
Kasius JC; Pijnenborg JMA; Lindemann K; Forsse D; van Zwol J; Kristensen GB; Krakstad C; Werner HMJ; Amant F
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831000
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.
de Freitas D; Aguiar FN; Anton C; de Almeida DC; Bacchi CE; Carvalho JP; Carvalho FM
Heliyon; 2023 Jun; 9(6):e17495. PubMed ID: 37408903
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage.
Balaya V; Guani B; Magaud L; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F; On Behalf Of The Senticol Group
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260758
[TBL] [Abstract][Full Text] [Related]
15. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Staging of Endometrial Carcinomas: Selected Areas of Difficulty.
McCluggage WG
Adv Anat Pathol; 2018 Mar; 25(2):71-84. PubMed ID: 29356713
[TBL] [Abstract][Full Text] [Related]
17. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Lymph Node Metastasis in Surgically Staged FIGO IA G1/G2 Endometrial Cancer With a Tumor Size of More Than 2 cm.
Boyraz G; Salman MC; Gultekin M; Basaran D; Cagan M; Ozgul N; Yuce K
Int J Gynecol Cancer; 2017 Mar; 27(3):486-492. PubMed ID: 28187095
[TBL] [Abstract][Full Text] [Related]
19. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
[TBL] [Abstract][Full Text] [Related]
20. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
Ballester M; Koskas M; Coutant C; Chéreau E; Seror J; Rouzier R; Daraï E
BMC Cancer; 2010 Aug; 10():465. PubMed ID: 20804553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
